Inhibition of Ribonucleotide Reductase Subunit 2 (RRM2) Induces Radiosensitization in Gastroenteropancreatic Neuroendocrine Tumors

被引：0
|
作者：
Chow, Z. [1 ]
Johnson, J. [1 ]
Chauhan, A. [1 ]
Izumi, T. [1 ]
Cavnar, M. [1 ]
Weiss, H. [1 ]
Anthony, L. [1 ]
Evers, B. M. [1 ]
Rychahou, P. [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1113
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [31] A NOVEL GALLIUM COMPOUND DISRUPTS TUMOR IRON HOMEOSTASIS AND RETARDS THE GROWTH OF GLIOBLASTOMA IN VIVO BY INHIBITING THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE (RRM2)
    Chitambar, Christopher
    Al-Gizawiy, Mona
    Lozen, Andrew
    Pechman, Kimberly
    Wereley, Janine
    Wujek, Robert
    Clark, Paul
    Kuo, John
    Elford, Howard
    Hedlund, Bo
    Joshi, Devashish
    Antholine, William
    Schmainda, Kathleen
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E213 - E213
  • [32] Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression.
    Mazzu, Ying Zhang
    Armenia, Joshua
    Chakraborty, Goutam
    Yoshikawa, Yuki
    Gerke, Travis A.
    Atiq, Mohammad Omar
    Stopsack, Konrad Hermann
    Komura, Kazumasa
    Lee, Gwo-Shu Mary
    Mucci, Lorelei A.
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] RRM2 inhibition by COH29 is a potential therapeutic strategy for atypical teratoid rhabdoid tumors
    Giang, Le Hien
    Wong, Tai-Tong
    Chang, Che-Chang
    CANCER RESEARCH, 2023, 83 (07)
  • [34] AKT-Induced Tamoxifen Resistance Is Overturned by RRM2 Inhibition
    Shah, Khyati N.
    Mehta, Kshama R.
    Peterson, David
    Evangelista, Marie
    Livesey, John C.
    Faridi, Jesika S.
    MOLECULAR CANCER RESEARCH, 2014, 12 (03) : 394 - 407
  • [35] RRM2 inhibition synergizes with PARP inhibitor in ovarian cancer cells
    Chen, Chi-Wei
    CANCER RESEARCH, 2023, 83 (07)
  • [36] Cyclooxygenase-2 expression in gastroenteropancreatic neuroendocrine tumors
    Ince, Ali Tuzun
    Ovunc, Oya
    Celikel, Cigdem Ataizi
    Goksel, Suha
    Tosun, Serhan
    Peker, Oender
    HEPATO-GASTROENTEROLOGY, 2007, 54 (76) : 1125 - 1129
  • [37] Ribonulceotide Reductase M2 (RRM2): Predictive Marker of Response to Gemcitabine in Pancreatic Cancer
    Farrell, James J.
    Garcia, Miguel
    Liu, Xiyong
    Ammar, Ali
    Regine, William F.
    Abrams, Ross A.
    Elsaleh, Hany
    GASTROENTEROLOGY, 2009, 136 (05) : A32 - A32
  • [38] Ribonucleotide reductase subunit-2 (RRM2) and thymidylate synthase (TS) to predict shorter survival in patients (pts) with resected stage I-III non-small cell lung cancer (NSCLC)
    Grossi, Francesco
    Dal Bello, Maria Giovanna
    Savarino, Graziana
    Salvi, Sandra
    Puzone, Roberto
    Pfeffer, Ulrich
    Fontana, Vincenzo
    Rijavec, Erika
    Genova, Giulia Barletta Carlo
    Sini, Claudio
    Ratto, Giovanni Battista
    Truini, Mauro
    Merlo, Domenico Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer
    Wu, Liyuan
    Yin, Le
    Ma, Linxiang
    Yang, Jiarui
    Yang, Feiya
    Sun, Baofa
    Xing Nianzeng
    AGING-US, 2022, 14 (19): : 7890 - 7905
  • [40] Neuroendocrine tumors of the gastroenteropancreatic system .2. Therapeutic advances
    Scherubl, H
    Buhr, H
    Faiss, S
    Zimmer, T
    Riecken, EO
    Wiedenmann, B
    ONKOLOGIE, 1996, 19 (03): : 214 - 219
12345